4//SEC Filing
Wills Robert James 4
Accession 0001209191-24-005154
CIK 0001260990other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 7:00 PM ET
Size
5.6 KB
Accession
0001209191-24-005154
Insider Transaction Report
Form 4
Wills Robert James
DirectorExecutive Chairman
Transactions
- Purchase
Common Stock
2024-03-28$8.48/sh+6,914$58,602→ 6,914 total
Footnotes (2)
- [F1]The Reporting Person's common stock purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 980 shares at a weighted average price per share of $8.1548, with the sale of 980 shares of common stock at a price per share of $9.04 on February 23, 2024. The Reporting Person has agreed to pay the issuer $867.51, representing the full amount of the profit realized in connection with the short-swing transaction.
- [F2]The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $8.095 to $9.00. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001634189
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 7:00 PM ET
- Size
- 5.6 KB